Global Veterinary API Market

Veterinary API Comprehensive Study by Type (Parasiticides, Anti-inflammatory, Antimicrobials, Vaccines, Hormones, Others), Route of Administration (Oral, Injectable, Topical, Others), Synthesis Type (Chemical, Biological, HPAPI) Players and Region - Global Market Outlook to 2030

Veterinary API Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Veterinary API
Veterinary APIs, which stands for Veterinary Active Pharmaceutical Ingredients, are the essential components that produce the intended effect in veterinary medicines. Just like human medications, veterinary drugs have specific ingredients that cause the desired therapeutic outcome in animals. Veterinary APIs are the building blocks for these medications. Veterinary APIs (Active Pharmaceutical Ingredients) are the essential elements that make veterinary drugs work. They are the building blocks used to manufacture medications for animals, similar to how human medications are produced. By addressing these trends and implementing these growth strategies, the veterinary API market is well-positioned for continued expansion in the foreseeable future.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The global Veterinary API market is moderately competitive and covers the various market growth key players. In terms of market share, some manufacturers are presently dominating the global market. These market players are focusing on strategic business initiatives to enhance their market share and improve their overall business profitability. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Veterinary API market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Boehringer Ingelheim International GmbH (Germany), Zoetis, Inc. (United States), Elanco Animal Health, Inc. (United States), Merck & Co., Inc. (United States), Virbac (France), Vetoquinol SA (France), Sequent Scientific Limited (India), Phibro Animal Health Corporation (United States), Febbrica Italina Sintetici S.P.A. (Nine Trees Group S.p.A) (Italy) and Excel Industries Limited (India) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Menadione (Spain), LasaSupergenerics Ltd. (India), Excel Veterinary HealthcareVetpharma (Argentina), Huvepharma (Bulgaria) and Jiangsu Lingyun Pharmaceutical Co. Ltd (China).

Segmentation Overview
AMA Research has segmented the market of Global Veterinary API market by Type (Parasiticides, Anti-inflammatory, Antimicrobials, Vaccines, Hormones and Others) and Region.



On the basis of geography, the market of Veterinary API has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Route of Administration, the sub-segment i.e. Oral will boost the Veterinary API market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Synthesis Type, the sub-segment i.e. Chemical will boost the Veterinary API market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Growing awareness on animal healthcare

Market Growth Drivers:
Rising prevalence of animal diseases and Growing focus on preventive healthcare

Challenges:
Increasing concern about antibiotic resistance in animals

Restraints:
Difficulties in large-molecular-weight API synthesis

Opportunities:
Increasing investment in Pharmaceutical companies and Expansion of Livestock Production

Market Leaders and their expansionary development strategies
In March 2023, Willow Biosciences and SUANFARMA jointly announced execution of a collaboration agreement for a cell line productivity optimization development program for manufacturing a large volume anti-infective Active Pharmaceutical Ingredient (“API”) through precision fermentation. Through the partnership, SUANFARMA will have access to Willow’s proprietary strain optimization technologies to develop a more cost-effective production process.
In December 2022, eVerse.AI which is a leading technology company operating in Dairy, Agriculture and Sustainability space has launched CowGPT. It is the world's first Generative AI application purpose built for this space. Generative AI has been creating a lot of buzz in the industry for a year or so and it has already started transforming several industries at a rapid pace.


Key Target Audience
Manufacturing companies, Potential Investors, Market & Research Consultancy Firm, Research & Development Institutes and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Parasiticides
  • Anti-inflammatory
  • Antimicrobials
  • Vaccines
  • Hormones
  • Others
By Route of Administration
  • Oral
  • Injectable
  • Topical
  • Others

By Synthesis Type
  • Chemical
  • Biological
  • HPAPI

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising prevalence of animal diseases
      • 3.2.2. Growing focus on preventive healthcare
    • 3.3. Market Challenges
      • 3.3.1. Increasing concern about antibiotic resistance in animals
    • 3.4. Market Trends
      • 3.4.1. Growing awareness on animal healthcare
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Veterinary API, by Type, Route of Administration, Synthesis Type and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Veterinary API (Value)
      • 5.2.1. Global Veterinary API by: Type (Value)
        • 5.2.1.1. Parasiticides
        • 5.2.1.2. Anti-inflammatory
        • 5.2.1.3. Antimicrobials
        • 5.2.1.4. Vaccines
        • 5.2.1.5. Hormones
        • 5.2.1.6. Others
      • 5.2.2. Global Veterinary API by: Route of Administration (Value)
        • 5.2.2.1. Oral
        • 5.2.2.2. Injectable
        • 5.2.2.3. Topical
        • 5.2.2.4. Others
      • 5.2.3. Global Veterinary API by: Synthesis Type (Value)
        • 5.2.3.1. Chemical
        • 5.2.3.2. Biological
        • 5.2.3.3. HPAPI
      • 5.2.4. Global Veterinary API Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Veterinary API: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Boehringer Ingelheim International GmbH (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Zoetis, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Elanco Animal Health, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Merck & Co., Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Virbac (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Vetoquinol SA (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Sequent Scientific Limited (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Phibro Animal Health Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Febbrica Italina Sintetici S.P.A. (Nine Trees Group S.p.A) (Italy)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Excel Industries Limited (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Veterinary API Sale, by Type, Route of Administration, Synthesis Type and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Veterinary API (Value)
      • 7.2.1. Global Veterinary API by: Type (Value)
        • 7.2.1.1. Parasiticides
        • 7.2.1.2. Anti-inflammatory
        • 7.2.1.3. Antimicrobials
        • 7.2.1.4. Vaccines
        • 7.2.1.5. Hormones
        • 7.2.1.6. Others
      • 7.2.2. Global Veterinary API by: Route of Administration (Value)
        • 7.2.2.1. Oral
        • 7.2.2.2. Injectable
        • 7.2.2.3. Topical
        • 7.2.2.4. Others
      • 7.2.3. Global Veterinary API by: Synthesis Type (Value)
        • 7.2.3.1. Chemical
        • 7.2.3.2. Biological
        • 7.2.3.3. HPAPI
      • 7.2.4. Global Veterinary API Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Veterinary API: by Type(USD Million)
  • Table 2. Veterinary API Parasiticides , by Region USD Million (2018-2023)
  • Table 3. Veterinary API Anti-inflammatory , by Region USD Million (2018-2023)
  • Table 4. Veterinary API Antimicrobials , by Region USD Million (2018-2023)
  • Table 5. Veterinary API Vaccines , by Region USD Million (2018-2023)
  • Table 6. Veterinary API Hormones , by Region USD Million (2018-2023)
  • Table 7. Veterinary API Others , by Region USD Million (2018-2023)
  • Table 8. Veterinary API: by Route of Administration(USD Million)
  • Table 9. Veterinary API Oral , by Region USD Million (2018-2023)
  • Table 10. Veterinary API Injectable , by Region USD Million (2018-2023)
  • Table 11. Veterinary API Topical , by Region USD Million (2018-2023)
  • Table 12. Veterinary API Others , by Region USD Million (2018-2023)
  • Table 13. Veterinary API: by Synthesis Type(USD Million)
  • Table 14. Veterinary API Chemical , by Region USD Million (2018-2023)
  • Table 15. Veterinary API Biological , by Region USD Million (2018-2023)
  • Table 16. Veterinary API HPAPI , by Region USD Million (2018-2023)
  • Table 17. South America Veterinary API, by Country USD Million (2018-2023)
  • Table 18. South America Veterinary API, by Type USD Million (2018-2023)
  • Table 19. South America Veterinary API, by Route of Administration USD Million (2018-2023)
  • Table 20. South America Veterinary API, by Synthesis Type USD Million (2018-2023)
  • Table 21. Brazil Veterinary API, by Type USD Million (2018-2023)
  • Table 22. Brazil Veterinary API, by Route of Administration USD Million (2018-2023)
  • Table 23. Brazil Veterinary API, by Synthesis Type USD Million (2018-2023)
  • Table 24. Argentina Veterinary API, by Type USD Million (2018-2023)
  • Table 25. Argentina Veterinary API, by Route of Administration USD Million (2018-2023)
  • Table 26. Argentina Veterinary API, by Synthesis Type USD Million (2018-2023)
  • Table 27. Rest of South America Veterinary API, by Type USD Million (2018-2023)
  • Table 28. Rest of South America Veterinary API, by Route of Administration USD Million (2018-2023)
  • Table 29. Rest of South America Veterinary API, by Synthesis Type USD Million (2018-2023)
  • Table 30. Asia Pacific Veterinary API, by Country USD Million (2018-2023)
  • Table 31. Asia Pacific Veterinary API, by Type USD Million (2018-2023)
  • Table 32. Asia Pacific Veterinary API, by Route of Administration USD Million (2018-2023)
  • Table 33. Asia Pacific Veterinary API, by Synthesis Type USD Million (2018-2023)
  • Table 34. China Veterinary API, by Type USD Million (2018-2023)
  • Table 35. China Veterinary API, by Route of Administration USD Million (2018-2023)
  • Table 36. China Veterinary API, by Synthesis Type USD Million (2018-2023)
  • Table 37. Japan Veterinary API, by Type USD Million (2018-2023)
  • Table 38. Japan Veterinary API, by Route of Administration USD Million (2018-2023)
  • Table 39. Japan Veterinary API, by Synthesis Type USD Million (2018-2023)
  • Table 40. India Veterinary API, by Type USD Million (2018-2023)
  • Table 41. India Veterinary API, by Route of Administration USD Million (2018-2023)
  • Table 42. India Veterinary API, by Synthesis Type USD Million (2018-2023)
  • Table 43. South Korea Veterinary API, by Type USD Million (2018-2023)
  • Table 44. South Korea Veterinary API, by Route of Administration USD Million (2018-2023)
  • Table 45. South Korea Veterinary API, by Synthesis Type USD Million (2018-2023)
  • Table 46. Taiwan Veterinary API, by Type USD Million (2018-2023)
  • Table 47. Taiwan Veterinary API, by Route of Administration USD Million (2018-2023)
  • Table 48. Taiwan Veterinary API, by Synthesis Type USD Million (2018-2023)
  • Table 49. Australia Veterinary API, by Type USD Million (2018-2023)
  • Table 50. Australia Veterinary API, by Route of Administration USD Million (2018-2023)
  • Table 51. Australia Veterinary API, by Synthesis Type USD Million (2018-2023)
  • Table 52. Rest of Asia-Pacific Veterinary API, by Type USD Million (2018-2023)
  • Table 53. Rest of Asia-Pacific Veterinary API, by Route of Administration USD Million (2018-2023)
  • Table 54. Rest of Asia-Pacific Veterinary API, by Synthesis Type USD Million (2018-2023)
  • Table 55. Europe Veterinary API, by Country USD Million (2018-2023)
  • Table 56. Europe Veterinary API, by Type USD Million (2018-2023)
  • Table 57. Europe Veterinary API, by Route of Administration USD Million (2018-2023)
  • Table 58. Europe Veterinary API, by Synthesis Type USD Million (2018-2023)
  • Table 59. Germany Veterinary API, by Type USD Million (2018-2023)
  • Table 60. Germany Veterinary API, by Route of Administration USD Million (2018-2023)
  • Table 61. Germany Veterinary API, by Synthesis Type USD Million (2018-2023)
  • Table 62. France Veterinary API, by Type USD Million (2018-2023)
  • Table 63. France Veterinary API, by Route of Administration USD Million (2018-2023)
  • Table 64. France Veterinary API, by Synthesis Type USD Million (2018-2023)
  • Table 65. Italy Veterinary API, by Type USD Million (2018-2023)
  • Table 66. Italy Veterinary API, by Route of Administration USD Million (2018-2023)
  • Table 67. Italy Veterinary API, by Synthesis Type USD Million (2018-2023)
  • Table 68. United Kingdom Veterinary API, by Type USD Million (2018-2023)
  • Table 69. United Kingdom Veterinary API, by Route of Administration USD Million (2018-2023)
  • Table 70. United Kingdom Veterinary API, by Synthesis Type USD Million (2018-2023)
  • Table 71. Netherlands Veterinary API, by Type USD Million (2018-2023)
  • Table 72. Netherlands Veterinary API, by Route of Administration USD Million (2018-2023)
  • Table 73. Netherlands Veterinary API, by Synthesis Type USD Million (2018-2023)
  • Table 74. Rest of Europe Veterinary API, by Type USD Million (2018-2023)
  • Table 75. Rest of Europe Veterinary API, by Route of Administration USD Million (2018-2023)
  • Table 76. Rest of Europe Veterinary API, by Synthesis Type USD Million (2018-2023)
  • Table 77. MEA Veterinary API, by Country USD Million (2018-2023)
  • Table 78. MEA Veterinary API, by Type USD Million (2018-2023)
  • Table 79. MEA Veterinary API, by Route of Administration USD Million (2018-2023)
  • Table 80. MEA Veterinary API, by Synthesis Type USD Million (2018-2023)
  • Table 81. Middle East Veterinary API, by Type USD Million (2018-2023)
  • Table 82. Middle East Veterinary API, by Route of Administration USD Million (2018-2023)
  • Table 83. Middle East Veterinary API, by Synthesis Type USD Million (2018-2023)
  • Table 84. Africa Veterinary API, by Type USD Million (2018-2023)
  • Table 85. Africa Veterinary API, by Route of Administration USD Million (2018-2023)
  • Table 86. Africa Veterinary API, by Synthesis Type USD Million (2018-2023)
  • Table 87. North America Veterinary API, by Country USD Million (2018-2023)
  • Table 88. North America Veterinary API, by Type USD Million (2018-2023)
  • Table 89. North America Veterinary API, by Route of Administration USD Million (2018-2023)
  • Table 90. North America Veterinary API, by Synthesis Type USD Million (2018-2023)
  • Table 91. United States Veterinary API, by Type USD Million (2018-2023)
  • Table 92. United States Veterinary API, by Route of Administration USD Million (2018-2023)
  • Table 93. United States Veterinary API, by Synthesis Type USD Million (2018-2023)
  • Table 94. Canada Veterinary API, by Type USD Million (2018-2023)
  • Table 95. Canada Veterinary API, by Route of Administration USD Million (2018-2023)
  • Table 96. Canada Veterinary API, by Synthesis Type USD Million (2018-2023)
  • Table 97. Mexico Veterinary API, by Type USD Million (2018-2023)
  • Table 98. Mexico Veterinary API, by Route of Administration USD Million (2018-2023)
  • Table 99. Mexico Veterinary API, by Synthesis Type USD Million (2018-2023)
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Veterinary API: by Type(USD Million)
  • Table 111. Veterinary API Parasiticides , by Region USD Million (2025-2030)
  • Table 112. Veterinary API Anti-inflammatory , by Region USD Million (2025-2030)
  • Table 113. Veterinary API Antimicrobials , by Region USD Million (2025-2030)
  • Table 114. Veterinary API Vaccines , by Region USD Million (2025-2030)
  • Table 115. Veterinary API Hormones , by Region USD Million (2025-2030)
  • Table 116. Veterinary API Others , by Region USD Million (2025-2030)
  • Table 117. Veterinary API: by Route of Administration(USD Million)
  • Table 118. Veterinary API Oral , by Region USD Million (2025-2030)
  • Table 119. Veterinary API Injectable , by Region USD Million (2025-2030)
  • Table 120. Veterinary API Topical , by Region USD Million (2025-2030)
  • Table 121. Veterinary API Others , by Region USD Million (2025-2030)
  • Table 122. Veterinary API: by Synthesis Type(USD Million)
  • Table 123. Veterinary API Chemical , by Region USD Million (2025-2030)
  • Table 124. Veterinary API Biological , by Region USD Million (2025-2030)
  • Table 125. Veterinary API HPAPI , by Region USD Million (2025-2030)
  • Table 126. South America Veterinary API, by Country USD Million (2025-2030)
  • Table 127. South America Veterinary API, by Type USD Million (2025-2030)
  • Table 128. South America Veterinary API, by Route of Administration USD Million (2025-2030)
  • Table 129. South America Veterinary API, by Synthesis Type USD Million (2025-2030)
  • Table 130. Brazil Veterinary API, by Type USD Million (2025-2030)
  • Table 131. Brazil Veterinary API, by Route of Administration USD Million (2025-2030)
  • Table 132. Brazil Veterinary API, by Synthesis Type USD Million (2025-2030)
  • Table 133. Argentina Veterinary API, by Type USD Million (2025-2030)
  • Table 134. Argentina Veterinary API, by Route of Administration USD Million (2025-2030)
  • Table 135. Argentina Veterinary API, by Synthesis Type USD Million (2025-2030)
  • Table 136. Rest of South America Veterinary API, by Type USD Million (2025-2030)
  • Table 137. Rest of South America Veterinary API, by Route of Administration USD Million (2025-2030)
  • Table 138. Rest of South America Veterinary API, by Synthesis Type USD Million (2025-2030)
  • Table 139. Asia Pacific Veterinary API, by Country USD Million (2025-2030)
  • Table 140. Asia Pacific Veterinary API, by Type USD Million (2025-2030)
  • Table 141. Asia Pacific Veterinary API, by Route of Administration USD Million (2025-2030)
  • Table 142. Asia Pacific Veterinary API, by Synthesis Type USD Million (2025-2030)
  • Table 143. China Veterinary API, by Type USD Million (2025-2030)
  • Table 144. China Veterinary API, by Route of Administration USD Million (2025-2030)
  • Table 145. China Veterinary API, by Synthesis Type USD Million (2025-2030)
  • Table 146. Japan Veterinary API, by Type USD Million (2025-2030)
  • Table 147. Japan Veterinary API, by Route of Administration USD Million (2025-2030)
  • Table 148. Japan Veterinary API, by Synthesis Type USD Million (2025-2030)
  • Table 149. India Veterinary API, by Type USD Million (2025-2030)
  • Table 150. India Veterinary API, by Route of Administration USD Million (2025-2030)
  • Table 151. India Veterinary API, by Synthesis Type USD Million (2025-2030)
  • Table 152. South Korea Veterinary API, by Type USD Million (2025-2030)
  • Table 153. South Korea Veterinary API, by Route of Administration USD Million (2025-2030)
  • Table 154. South Korea Veterinary API, by Synthesis Type USD Million (2025-2030)
  • Table 155. Taiwan Veterinary API, by Type USD Million (2025-2030)
  • Table 156. Taiwan Veterinary API, by Route of Administration USD Million (2025-2030)
  • Table 157. Taiwan Veterinary API, by Synthesis Type USD Million (2025-2030)
  • Table 158. Australia Veterinary API, by Type USD Million (2025-2030)
  • Table 159. Australia Veterinary API, by Route of Administration USD Million (2025-2030)
  • Table 160. Australia Veterinary API, by Synthesis Type USD Million (2025-2030)
  • Table 161. Rest of Asia-Pacific Veterinary API, by Type USD Million (2025-2030)
  • Table 162. Rest of Asia-Pacific Veterinary API, by Route of Administration USD Million (2025-2030)
  • Table 163. Rest of Asia-Pacific Veterinary API, by Synthesis Type USD Million (2025-2030)
  • Table 164. Europe Veterinary API, by Country USD Million (2025-2030)
  • Table 165. Europe Veterinary API, by Type USD Million (2025-2030)
  • Table 166. Europe Veterinary API, by Route of Administration USD Million (2025-2030)
  • Table 167. Europe Veterinary API, by Synthesis Type USD Million (2025-2030)
  • Table 168. Germany Veterinary API, by Type USD Million (2025-2030)
  • Table 169. Germany Veterinary API, by Route of Administration USD Million (2025-2030)
  • Table 170. Germany Veterinary API, by Synthesis Type USD Million (2025-2030)
  • Table 171. France Veterinary API, by Type USD Million (2025-2030)
  • Table 172. France Veterinary API, by Route of Administration USD Million (2025-2030)
  • Table 173. France Veterinary API, by Synthesis Type USD Million (2025-2030)
  • Table 174. Italy Veterinary API, by Type USD Million (2025-2030)
  • Table 175. Italy Veterinary API, by Route of Administration USD Million (2025-2030)
  • Table 176. Italy Veterinary API, by Synthesis Type USD Million (2025-2030)
  • Table 177. United Kingdom Veterinary API, by Type USD Million (2025-2030)
  • Table 178. United Kingdom Veterinary API, by Route of Administration USD Million (2025-2030)
  • Table 179. United Kingdom Veterinary API, by Synthesis Type USD Million (2025-2030)
  • Table 180. Netherlands Veterinary API, by Type USD Million (2025-2030)
  • Table 181. Netherlands Veterinary API, by Route of Administration USD Million (2025-2030)
  • Table 182. Netherlands Veterinary API, by Synthesis Type USD Million (2025-2030)
  • Table 183. Rest of Europe Veterinary API, by Type USD Million (2025-2030)
  • Table 184. Rest of Europe Veterinary API, by Route of Administration USD Million (2025-2030)
  • Table 185. Rest of Europe Veterinary API, by Synthesis Type USD Million (2025-2030)
  • Table 186. MEA Veterinary API, by Country USD Million (2025-2030)
  • Table 187. MEA Veterinary API, by Type USD Million (2025-2030)
  • Table 188. MEA Veterinary API, by Route of Administration USD Million (2025-2030)
  • Table 189. MEA Veterinary API, by Synthesis Type USD Million (2025-2030)
  • Table 190. Middle East Veterinary API, by Type USD Million (2025-2030)
  • Table 191. Middle East Veterinary API, by Route of Administration USD Million (2025-2030)
  • Table 192. Middle East Veterinary API, by Synthesis Type USD Million (2025-2030)
  • Table 193. Africa Veterinary API, by Type USD Million (2025-2030)
  • Table 194. Africa Veterinary API, by Route of Administration USD Million (2025-2030)
  • Table 195. Africa Veterinary API, by Synthesis Type USD Million (2025-2030)
  • Table 196. North America Veterinary API, by Country USD Million (2025-2030)
  • Table 197. North America Veterinary API, by Type USD Million (2025-2030)
  • Table 198. North America Veterinary API, by Route of Administration USD Million (2025-2030)
  • Table 199. North America Veterinary API, by Synthesis Type USD Million (2025-2030)
  • Table 200. United States Veterinary API, by Type USD Million (2025-2030)
  • Table 201. United States Veterinary API, by Route of Administration USD Million (2025-2030)
  • Table 202. United States Veterinary API, by Synthesis Type USD Million (2025-2030)
  • Table 203. Canada Veterinary API, by Type USD Million (2025-2030)
  • Table 204. Canada Veterinary API, by Route of Administration USD Million (2025-2030)
  • Table 205. Canada Veterinary API, by Synthesis Type USD Million (2025-2030)
  • Table 206. Mexico Veterinary API, by Type USD Million (2025-2030)
  • Table 207. Mexico Veterinary API, by Route of Administration USD Million (2025-2030)
  • Table 208. Mexico Veterinary API, by Synthesis Type USD Million (2025-2030)
  • Table 209. Research Programs/Design for This Report
  • Table 210. Key Data Information from Secondary Sources
  • Table 211. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Veterinary API: by Type USD Million (2018-2023)
  • Figure 5. Global Veterinary API: by Route of Administration USD Million (2018-2023)
  • Figure 6. Global Veterinary API: by Synthesis Type USD Million (2018-2023)
  • Figure 7. South America Veterinary API Share (%), by Country
  • Figure 8. Asia Pacific Veterinary API Share (%), by Country
  • Figure 9. Europe Veterinary API Share (%), by Country
  • Figure 10. MEA Veterinary API Share (%), by Country
  • Figure 11. North America Veterinary API Share (%), by Country
  • Figure 12. Global Veterinary API share by Players 2023 (%)
  • Figure 13. Global Veterinary API share by Players (Top 3) 2023(%)
  • Figure 14. Global Veterinary API share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Boehringer Ingelheim International GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 17. Boehringer Ingelheim International GmbH (Germany) Revenue: by Geography 2023
  • Figure 18. Zoetis, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Zoetis, Inc. (United States) Revenue: by Geography 2023
  • Figure 20. Elanco Animal Health, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Elanco Animal Health, Inc. (United States) Revenue: by Geography 2023
  • Figure 22. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Merck & Co., Inc. (United States) Revenue: by Geography 2023
  • Figure 24. Virbac (France) Revenue, Net Income and Gross profit
  • Figure 25. Virbac (France) Revenue: by Geography 2023
  • Figure 26. Vetoquinol SA (France) Revenue, Net Income and Gross profit
  • Figure 27. Vetoquinol SA (France) Revenue: by Geography 2023
  • Figure 28. Sequent Scientific Limited (India) Revenue, Net Income and Gross profit
  • Figure 29. Sequent Scientific Limited (India) Revenue: by Geography 2023
  • Figure 30. Phibro Animal Health Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 31. Phibro Animal Health Corporation (United States) Revenue: by Geography 2023
  • Figure 32. Febbrica Italina Sintetici S.P.A. (Nine Trees Group S.p.A) (Italy) Revenue, Net Income and Gross profit
  • Figure 33. Febbrica Italina Sintetici S.P.A. (Nine Trees Group S.p.A) (Italy) Revenue: by Geography 2023
  • Figure 34. Excel Industries Limited (India) Revenue, Net Income and Gross profit
  • Figure 35. Excel Industries Limited (India) Revenue: by Geography 2023
  • Figure 36. Global Veterinary API: by Type USD Million (2025-2030)
  • Figure 37. Global Veterinary API: by Route of Administration USD Million (2025-2030)
  • Figure 38. Global Veterinary API: by Synthesis Type USD Million (2025-2030)
  • Figure 39. South America Veterinary API Share (%), by Country
  • Figure 40. Asia Pacific Veterinary API Share (%), by Country
  • Figure 41. Europe Veterinary API Share (%), by Country
  • Figure 42. MEA Veterinary API Share (%), by Country
  • Figure 43. North America Veterinary API Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Boehringer Ingelheim International GmbH (Germany)
  • Zoetis, Inc. (United States)
  • Elanco Animal Health, Inc. (United States)
  • Merck & Co., Inc. (United States)
  • Virbac (France)
  • Vetoquinol SA (France)
  • Sequent Scientific Limited (India)
  • Phibro Animal Health Corporation (United States)
  • Febbrica Italina Sintetici S.P.A. (Nine Trees Group S.p.A) (Italy)
  • Excel Industries Limited (India)
Additional players considered in the study are as follows:
Menadione (Spain) , LasaSupergenerics Ltd. (India) , Excel Veterinary HealthcareVetpharma (Argentina) , Huvepharma (Bulgaria) , Jiangsu Lingyun Pharmaceutical Co. Ltd (China)
Select User Access Type

Key Highlights of Report


May 2024 248 Pages 57 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Veterinary API Market Quantitative research analysis
Global Veterinary API Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Boehringer Ingelheim International GmbH (Germany), Zoetis, Inc. (United States), Elanco Animal Health, Inc. (United States), Merck & Co., Inc. (United States), Virbac (France), Vetoquinol SA (France), Sequent Scientific Limited (India), Phibro Animal Health Corporation (United States), Febbrica Italina Sintetici S.P.A. (Nine Trees Group S.p.A) (Italy) and Excel Industries Limited (India) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Growing awareness on animal healthcare" is seen as one of major influencing trends for Veterinary API Market during projected period 2023-2030.
The Veterinary API market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Veterinary API Market Report?

Have a Query? Click Here

Other Related Reports

Healthcare Payer & Healthcare Providers Comprehensive Study by Type (Payers Outlook, Public Payers (Medicare, Medicaid), Private Payers (Health Maintenance Organizations (HMOs), Preferred Provider Or...
$ 3800
Veterinary Hospital Comprehensive Study by Ownership (Private, Public), Animal Type (Companion Animals, Farm Animals), Service Type (Surgical Veterinary services, Diagnostic Services, Consultation Se...
$ 3800
Digestive Health Supplements Market Comprehensive Study by Type (Prebiotics, Probiotics, Enzymes, Other), Form (Capsules, Tablets, Powder, Liquid, Soft Gels, Others), Distribution Channel (Hypermarke...
$ 3800